Stem Cell Cryopreservation Market Size
| Study Period | 2019 - 2030 |
| Market Size (2025) | USD 4.81 Billion |
| Market Size (2030) | USD 11.89 Billion |
| CAGR (2025 - 2030) | 20.21% |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Low |
Major Players*Disclaimer: Major Players sorted in no particular order |
Stem Cell Cryopreservation Market Analysis
The Stem Cell Cryopreservation Market size is estimated at USD 4.81 billion in 2025, and is expected to reach USD 11.89 billion by 2030, at a CAGR of 20.21% during the forecast period (2025-2030).
Stem cell therapy, or regenerative medicine, promotes the repair response of diseased, dysfunctional, or injured tissue using stem cells or their derivatives. The cryopreservation procedure preserves the structural integrity of stem cells so that when they are unfrozen from storage, they can function again in stem cell therapy. The major factors driving the studied market are the growing demand for regenerative medicine, technological advancements in stem cell research, increasing clinical applications of stem cells, the growing prevalence of chronic diseases, and rising strategic activities by the key players in the market.
For instance, according to an article published in the Frontiers in Medicine in August 2023, stem cell therapy has continued to advance, bringing hope to cure diseases that were once considered incurable. The most widely adopted stem cell therapy is the transplantation of hematopoietic stem cells to treat hematological malignancies and disorders of the immune system and blood. According to the same source, in recent years, the use of stem cells has expanded into multiple fields of medicine. Experiments have been performed to generate insulin-secreting cells, neural cells, heart cells, and other tissue-specific cells ex vivo and in experimental animals. Hence, the increasing utility of cryopreserved stem cells in regenerative medicine is expected to drive the studied market over the forecast period.
Furthermore, the increasing investment in stem cell therapy research is also expected to increase stem cell cryopreservation, which will effectively use these cells to discover novel therapeutics that can be used in the treatment of various chronic diseases. For instance, in October 2023, Bayer AG, a pharmaceutical company, reported the establishment of a cell therapy facility in Berkeley, California, to create the capacity to bring cell therapies to patients on a global scale. The USD 250 million, 100,000-square-foot facility is expected supply the material required for late-stage clinical trials and the potential commercial launch of BlueRock Therapeutics’ bemdaneprocel (BRT-DA01), which is an investigational cell therapy designed to replace the dopamine-producing neurons that are lost in Parkinson’s disease.
As a result, these dopaminergic neuron precursors are derived from pluripotent stem cells (PSC), which are human embryonic stem cells. Hence, the establishment of such facilities increases the utilization of stem cell cryopreservation equipment and drives the studied market over the forecast period.
Thus, the increasing demand for regenerative medicine and increasing investments in stem cell therapy research activities are expected to increase the demand for the stem cell cryopreservation process, which will ultimately drive the studied market over the forecast period. However, the high cost of the stem cell cryopreservation process is expected to restrain the studied market over the forecast period.
Stem Cell Cryopreservation Market Trends
Induced Pluripotent Stem Cell Segment is Expected to Hold Significant Market Share Over the Forecast Period.
Induced pluripotent stem cells are derived from skin or blood cells that have been reprogrammed back into an embryonic-like pluripotent state that enables the development of an unlimited source of any type of human cell needed for therapeutic purposes. Pluripotent stem cell (PSC) cultures are harvested and cryopreserved at the time they would normally be ready for usage. The major factors driving the segment growth are the increasing application of Induced pluripotent stem cells and growing strategic activities such as collaboration by the key market players in the market.
The increasing clinical applications of induced pluripotent stem cells drive the demand for cryopreservation media and equipment for stem cells' efficient utilization for various clinical purposes, which ultimately drives the studied market over the forecast period. For instance, according to an article published in Nature in April 2024, The induced pluripotent stem cell (iPSC) technology has transformed in vitro research and holds great promise to advance regenerative medicine. iPSCs have been widely applied to model human development and diseases, perform drug screening, and develop cell therapies. Hence, the various clinical advantages offered by pluripotent stem cells are expected to increase the demand for these cells, which further drives the demand for cryopreservation equipment and consumables for the effective storage of these cells, which ultimately drives the studied market over the forecast period.
Furthermore, the increasing strategic activities, such as product launches that are based on the induced pluripotent stem cells by key players, are also expected to increase the cryopreservation of these cells for large-scale manufacturing of novel therapies, which will ultimately drive the studied market over the forecast period.
For instance, in October 2024, Century Therapeutics and Bristol Myers Squibb reported a research collaboration and license agreement to develop and commercialize up to four induced pluripotent stem cell-derived, engineered natural killer cell and T cell programs for hematologic malignancies and solid tumors. The primary aim of the agreement is for Century to be responsible for the discovery of development candidates and preclinical development activities. Thereafter, Bristol Myers Squibb will be responsible for clinical development and commercialization activities subject to Century’s co-promotion rights on certain programs. Hence, such strategic activities are expected to increase the demand for cryopreserved induced pluripotent stem cells, which ultimately drive the studied market over the forecast period.
Thus, the increasing clinical applications of induced pluripotent stem cells and growing strategic activities, such as product launches by the key players in the market, are expected to drive the studied segment over
North America is Expected to Hold the Significant Market Share Over the Forecast Period
The stem cell cryopreservation market in North America is driven by factors such as growing awareness about regenerative medicine, increasing technological advancements, the high prevalence of chronic diseases, increasing investments in stem cell therapies, and rising strategic activities by key market players.
The increasing research activities for the development of stem cell therapies by using cryopreserved stem cells are expected to increase the demand for stem cell cryopreservation media and consumables, which ultimately drive the studied market over the forecast period. For instance, In November 2023, ACROBiosystems, a pharmaceutical company that offers innovative tools and solutions, launched GMP grade first recombinant Delta-like Ligand 4. The DLL4 was designed for stem cell culturing for biologics- manufacturing undergoing clinical trials and as a complementary partner to our research and premium-grade DLL4. It supports a streamlined path toward commercialization by minimizing data revalidation during IND submissions. This launch assists the company in accelerating biologics development and regulatory approval for the products.
Hence, such investments increase the utility of cryopreserved stem cells and increase the demand, which further drives the studied market over the forecast period.
Furthermore, the rising strategic activities, such as product launches by key market players, are also expected to drive the studied market over the forecast period in North America. For instance, in April 2024, Pluristyx, a provider of tools, technologies, and services for cellular therapies, reported the launch of PluriFreeze, a proprietary cryopreservation medium solution. This media is designed to support cell metabolism and ease pluripotent stem and other energetically active cells to and from the frozen state to enhance post-thaw viability and function. PluriFreeze offers significant benefits for cell therapy development that include an entirely synthetic and Animal-origin-free (AOF) composition, low viscosity for automation, and large-scale cell production. Hence, the launch of such products is expected to drive the studied market over the forecast period.
Hence, the increasing investment in research activities for the development of stem cell therapies and growing strategic activities by key market players are expected to drive the studied market over the forecast period.
Stem Cell Cryopreservation Industry Overview
The stem cell cryopreservation market is semiconsolidated due to the presence of many global and regional players in the field. The major players in the market are adopting various strategic activities such as mergers and collaborations and raising funds for the development of new solutions. Some of the key players in the market are Thermo Fisher Scientific Inc., Corning Incorporated, Lonza Group, Globus Medica, and StemCyte, among other players.
Stem Cell Cryopreservation Market Leaders
-
Corning Incorporated
-
Lonza Group
-
Globus Medica
-
StemCyte
-
Thermo Fisher Scientific Inc.
- *Disclaimer: Major Players sorted in no particular order
Stem Cell Cryopreservation Market News
- September 2024: CPC (Colder Products Company), a manufacturer of connection technologies used in biopharmaceutical processing, reported the launch of a new aseptic micro-connector that fits directly into the freeze cassettes used in cell and gene therapy (CGT) process. These connectors are also chemically compatible with harsh chemicals used in cryopreservation processes like dimethyl sulfoxide (DMSO) and the most commonly used tubing types in CGT development, including polyvinyl chloride (PVC).
- July 2024: Bioserve India, a provider of biotechnology and life sciences solutions, reported the launch of stem cell media products used in cryopreservation, stem cell reprogramming kits, and cellular assays. The launch of these products aims to support innovation in scientific research and drug development, as well as advancements in regenerative medicine and therapeutic discovery in the Indian market.
Stem Cell Cryopreservation Industry Segmentation
As per the scope of the report, cryopreservation of stem cells is a process of using low temperatures to preserve these stem cells without damaging their function. Stem cell transplantation represents a critical approach to treating many malignant and non-malignant diseases. The foundation for these approaches is the ability to cryopreserve stem cells for future use. The stem cell cryopreservation market is segmented into type of stem cell, product type, end-user, and geography.
By type of stem cell, the market is segmented into embryonic stem cell, adult stem cell, and induced pluripotent stem cell. By product type, the market is segmented into cell freezing media, equipment, and consumables. By end user, the market is segmented into biopharmaceutical companies, research institutes, blood banks, and in vitro fertilization (IVF) clinics. By geography, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The report also covers the estimated market sizes and trends for 17 countries across significant global regions. The report offers the value (in USD) for the above segments.
| By Type of Stem Cell | Embryonic Stem Cell | ||
| Adult Stem Cell | |||
| Induced Pluripotent Stem Cell | |||
| By Product Type | Cell Freezing Media | ||
| Equipment | |||
| Consumables | |||
| By End User | Biopharmaceutical Companies | ||
| Research Institutes | |||
| Blood Banks | |||
| In Vitro Fertilization (IVF) Clinics | |||
| Geography | North America | United States | |
| Canada | |||
| Mexico | |||
| Europe | Germany | ||
| United Kingdom | |||
| France | |||
| Italy | |||
| Spain | |||
| Rest of Europe | |||
| Asia-Pacific | China | ||
| Japan | |||
| India | |||
| Australia | |||
| South Korea | |||
| Rest of Asia-Pacific | |||
| Middle East and Africa | GCC | ||
| South Africa | |||
| Rest of Middle East and Africa | |||
| South America | Brazil | ||
| Argentina | |||
| Rest of South America | |||
| Embryonic Stem Cell |
| Adult Stem Cell |
| Induced Pluripotent Stem Cell |
| Cell Freezing Media |
| Equipment |
| Consumables |
| Biopharmaceutical Companies |
| Research Institutes |
| Blood Banks |
| In Vitro Fertilization (IVF) Clinics |
| North America | United States |
| Canada | |
| Mexico | |
| Europe | Germany |
| United Kingdom | |
| France | |
| Italy | |
| Spain | |
| Rest of Europe | |
| Asia-Pacific | China |
| Japan | |
| India | |
| Australia | |
| South Korea | |
| Rest of Asia-Pacific | |
| Middle East and Africa | GCC |
| South Africa | |
| Rest of Middle East and Africa | |
| South America | Brazil |
| Argentina | |
| Rest of South America |
Stem Cell Cryopreservation Market Research Faqs
How big is the Stem Cell Cryopreservation Market?
The Stem Cell Cryopreservation Market size is expected to reach USD 4.81 billion in 2025 and grow at a CAGR of 20.21% to reach USD 11.89 billion by 2030.
What is the current Stem Cell Cryopreservation Market size?
In 2025, the Stem Cell Cryopreservation Market size is expected to reach USD 4.81 billion.
Who are the key players in Stem Cell Cryopreservation Market?
Corning Incorporated, Lonza Group, Globus Medica, StemCyte and Thermo Fisher Scientific Inc. are the major companies operating in the Stem Cell Cryopreservation Market.
Which is the fastest growing region in Stem Cell Cryopreservation Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).
Which region has the biggest share in Stem Cell Cryopreservation Market?
In 2025, the North America accounts for the largest market share in Stem Cell Cryopreservation Market.
What years does this Stem Cell Cryopreservation Market cover, and what was the market size in 2024?
In 2024, the Stem Cell Cryopreservation Market size was estimated at USD 3.84 billion. The report covers the Stem Cell Cryopreservation Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Stem Cell Cryopreservation Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Stem Cell Cryopreservation Industry Report
Statistics for the 2025 Stem Cell Cryopreservation market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Stem Cell Cryopreservation analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.
